Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

Gilead Sciences News Editors

News Widget

Display the Gilead Sciences news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Gilead Sciences News

News on Gilead Sciences (Ticker: GILD) continually updated from thousands of sources around the net.

4 hrs ago | Freshnews

Gilead Sciences to Present at Two Upcoming Investor Conferences

FOSTER CITY, Calif. -- -- Gilead Sciences, Inc. announced today that the company will be webcasting its corporate presentation at two upcoming investor conferences: the Jefferies Global Healthcare Conference in New York and the Goldman Sachs Healthcare Conference in Rancho Palos Verdes, California.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Startups, Gilead Sciences, CGI Pharmaceuticals, Foster City, CA, Investment Banking, Financial Services, Jefferies Group, Investment Services, Goldman Sachs

Sat May 26, 2012

The Motley Fool

3 Health-Care Stocks Crushing the Market

May isn't in the books yet, but three health-care stocks have shot to the stratosphere.

Comment?

Related Topix: Healthcare Law, Law, Food and Drug Administration, Vertex, Biotech, Vertex Pharmaceuticals, Medicine, Healthcare Industry

Wed May 23, 2012

Freshnews

Gilead Files European Marketing Application for Boosting Agent Cobicistat

FOSTER CITY, Calif. -- -- Gilead Sciences, Inc. announced today that the Marketing Authorisation Application for cobicistat, submitted on April 26, 2012, has been validated by the European Medicines Agency .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Marketing, Startups, Gilead Sciences, CGI Pharmaceuticals, Foster City, CA, Norvir, Ritonavir (generic), Medication

Tue May 22, 2012

The Motley Fool

Too Little, Too Late for Achillion?

Keep track of the stocks that matter to you. Help yourself with the Fool's FREE and easy new watchlist service today.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Mon May 21, 2012

Seeking Alpha

Gilead Sciences Inc.: Strong Growth At A Low Price

Gilead Sciences Inc is an innovative healthcare company with a strong record of historical earnings growth and expectations for above-average growth into the future.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Startups, Gilead Sciences, Financial Markets

Sat May 19, 2012

EDGE

FDA Panel OKs Truvada for HIV Prevention

Truvada, a once-daily antiretroviral pill, is effective for preventing sexual transmission of HIV and should be approved as post-exposure prophylaxis, or PrEP, a Food and Drug Administration advisory committee voted last week.

5 comments

Related Topix: Food and Drug Administration, Gay/Lesbian, Biotech, Medicine, Healthcare Industry, Startups, Gilead Sciences, CGI Pharmaceuticals, Epidemic, Natural Disasters

PR-inside.com

New Market Report: Pharmasset, Inc (VRUS) - Financial and Strategic SWOT Analysis Review

Pharmasset, Inc. is a health care pharmaceutical company. The company is engaged in discovering, producing and commercializing medicines to treat viral infections.

Comment?

Related Topix: Pharmaceuticals, Pharmasset, Hepatitis, Medicine, Health, Biotech, Healthcare Industry

Thu May 17, 2012

Seeking Alpha

Biotech-Focused Baker Bros. $3.7B Fund Bought These 3 Big Winners And Sold Others In Q1

New York-based Hedge Fund Baker Bros. Advisors LLC, as of the most recent SEC 13-F Q1 filing , had $3.7 billion in equity assets, almost all invested in the biotech sector, and an increase from the $3.0 billion in Q4 and $2.3 billion in Q3 of 2011.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Startups, Gilead Sciences

Wall St. Cheat Sheet

Active Stock Alerts: Akorn, Maxwell Technologies, Netflix, Citi, Gilead Sciences May 17th

Netflix, Inc. : Needham believes that increases in Netflix's domestic streaming margins will be largely offset by a decline in higher margin DVD subscription revenues.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Netflix, Startups, Gilead Sciences, Maxwell Technologies, Semiconductors, Electronics, Akorn, Computers, CGI Pharmaceuticals

Wed May 16, 2012

Freshnews

Global Nanobiotechnology Industry

NEW YORK, May 16, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: This report analyzes the worldwide markets for Nanobiotechnology in US$ Million by the following Technology Segments: Nanomaterials , and Nanodevices/Tools. The report provides separate comprehensive analytics for the ... (more)

Comment?

Related Topix: Agilent Technologies, Startups, Biotech, Medicine, Healthcare Industry, Gilead Sciences, NanoBio, 9

Medical News

Newspapers examine concerns surrounding possible FDA approval of Truvada for PrEP

The New York Times and the Financial Times examine concerns expressed by AIDS activists and members of an FDA panel that last week recommended Gilead Sciences' antiretroviral drug Truvada be approved for pre-exposure prophylaxis to prevent HIV among healthy people at risk of contracting the virus .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Epidemic, Natural Disasters

Tue May 15, 2012

Seeking Alpha

2 Healthcare Companies To Buy, 2 To Hold

Healthcare costs have been on the rise. Annual medical costs increased almost 35% from 2006 to 2010, with healthcare spending rising 8% a year .

Comment?

Related Topix: Financial Markets, Biotech, Medicine, Amgen, Healthcare Industry, Financial Services, Renaissance Technologies, Investment Services

Mon May 14, 2012

The Motley Fool

A Step Closer to Quadrific Sales

The single, easiest way to keep track of all the stocks that matter... Your own personalized stock watchlist! It's a 100% FREE Motley Fool service... ) Quad HIV drug off the market -- an advisory panel recommended approving the drug by a 13-1 margin -- but they might result in extra monitoring for kidney complications once the Quad is on the ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

MarketNewsVideo

Monday's ETF Movers: BBH, LATM

In trading on Monday, the Biotech ETF is outperforming other ETFs, up about 0.5% on the day.

Comment?

Related Topix: Biotech, Vertex Pharmaceuticals, Medicine, Healthcare Industry, Startups, Gilead Sciences, CGI Pharmaceuticals, Business News, Video

Sat May 12, 2012

Charleston Gazette

AIDS fight enters new phase with prevention pill

Contact us Search archives Page Reprints Getting Into Print Weather Our History Privacy Statement RSS Feeds Advertising Webcams >> More blue AP Video News Politics Gazette Charities Business Police Blotter Watchdog News Columnists Putnam County Public records Special Reports Weird News Corrections Advisories >> More blue WVU Marshall Prep Sports ... (more)

Comment?

Related Topix: Media, Fox Filmed Entertainment, Blog News, Biotech, Medicine, Healthcare Industry, Epidemic, Natural Disasters

Fri May 11, 2012

Bloomberg

Gilead's Quad Pill Gains FDA Advisers Support as New Treatment for HIV

Gilead Sciences Inc. 's experimental HIV pill Quad, the new medicine from the world's largest maker of AIDS drugs, gained a U.S. advisory panel's backing to treat patients infected with the virus.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, HIV/AIDS, Health, Startups, Gilead Sciences, New York University, Infectious Diseases, Bristol Myers Squibb

The Campbell Reporter

Biz Break: Gilead pins hopes on HIV drug; Apple rumors; and chipmakers' outlook improves

Biz Break: Cisco drags tech stocks down, but two Silicon Valley IPOs find success; also, Microsoft uses Facebook to battle Google Biz Break: Microsoft looks at Nook for tablet anchor, Apple falls below $600 again, and a big day for cleantech This photo provided by Gilead Sciences shows Truvada.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, HIV/AIDS, Health, Apple, Startups, Financial Markets, Google, Gilead Sciences

Wall St. Cheat Sheet

Healthcare Business Recap: Gilead's FDA Halo, Pfizer Cuts Deals

Shares of Gilead continue to rise subsequent to Thursday's FDA advisory panel approval of the firm's HIV drug Truvada for use as a preventative measure in high-risk individuals.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, CGI Pharmaceuticals

The Washington Post

Gilead HIV Pill Wins FDA Panel Backing as First to Prevent Virus

Gilead Sciences Inc.'s HIV drug Truvada won the backing of a U.S. advisory panel as the first medicine to keep healthy people from getting the virus through sexual activity.

Comment?

Related Topix: HIV/AIDS, Health, Biotech, Medicine, Healthcare Industry, UC Berkeley, New York, Epidemic, Natural Disasters, Business News

Thu May 10, 2012

Freshnews

FDA Advisory Committee Supports Approval of Gilead's TruvadaA for...

FOSTER CITY, Calif. -- -- Gilead Sciences, Inc. today announced that the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration has voted to support approval of once-daily oral Truvada to reduce the risk of HIV-1 infection among uninfected adults, an HIV prevention strategy called pre-exposure prophylaxis or PrEP.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Foster City, CA, Startups, Gilead Sciences, Food and Drug Administration, CGI Pharmaceuticals, HIV/AIDS, Health

Los Angeles Jobs

Also on Topix